GRN and neoplasm: Future validation through in vivo experiments and additional clinical datasets will be critical to fully elucidate the therapeutic potential of GRN, including the genetics, epigenetics, and molecular mechanisms underlying its role in resistance, its downstream effectors, interactions within key signaling pathways, and the interplay between tumor-intrinsic and environmental features.